Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin.

Saved in:
Bibliographic Details
Title: Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin.
Authors: Jennemann, Richard1 (AUTHOR) r.jennemann@dkfz.de, Volz, Martina1 (AUTHOR), Frias-Soler, Roberto Carlos2,3 (AUTHOR), Schulze, Almut2 (AUTHOR), Richter, Karsten4 (AUTHOR), Kaden, Sylvia4 (AUTHOR), Sandhoff, Roger1 (AUTHOR)
Source: International Journal of Molecular Sciences. Jan2025, Vol. 26 Issue 1, p304. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms26010304